Hepatitis E Virus Infection During Pregnancy: The Overlooked Cause of Maternal and Fetal Mortality

Author(s): Fatemeh Farshadpour, Sakineh Taherkhani, Reza Taherkhani*.

Journal Name: Infectious Disorders - Drug Targets
(Formerly Current Drug Targets - Infectious Disorders)

Volume 19 , Issue 3 , 2019

Become EABM
Become Reviewer

Abstract:

Background: Hepatitis E virus (HEV) is one the leading causes of maternal and fetal mortality. Nevertheless, in some geographical locations, especially Egypt, despite having high frequency of HEV seropositivity, HEV infection follows an asymptomatic or mild course during pregnancy. These anomalous observations have distracted attention from the importance of HEV infection in pregnant women.

Methods: While tragic cases of HEV-infected pregnant women cannot be neglected any longer.

Conclusion: These circumstances create a strong demand for the increasing awareness of HEV infection through training programs, appropriate management of HEV infection among pregnant women, routine screening of pregnant women for timely diagnosis of HEV infection, proper treatment of HEVinfected patients, optimal preventive measures, and development of a prophylactic vaccine against HEV infection.

Keywords: Hepatitis E virus, pregnancy, maternal mortality, Fetal, benign.

[1]
Taherkhani, R.; Farshadpour, F. Epidemiology of hepatitis E virus in Iran. World J. Gastroenterol., 2016, 22(22), 5143-5153.
[http://dx.doi.org/10.3748/wjg.v22.i22.5143] [PMID: 27298557]
[2]
Kim, J.H.; Nelson, K.E.; Panzner, U.; Kasture, Y.; Labrique, A.B.; Wierzba, T.F. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect. Dis., 2014, 14, 308.
[http://dx.doi.org/10.1186/1471-2334-14-308] [PMID: 24902967]
[3]
Kar, P. Hepatitis E virus infection during pregnancy: Why is the disease stormy? Medicine Update, 2012, 22, 459-462.
[4]
El Sayed Zaki, M.; El Razek, M.M.; El Razek, H.M. Maternal-Fetal hepatitis E transmission: Is it underestimated? J. Clin. Transl. Hepatol., 2014, 2(2), 117-123.
[PMID: 26356414]
[5]
Taherkhani, R.; Makvandi, M.; Farshadpour, F. Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus. Ann. Lab. Med., 2014, 34(2), 118-126.
[http://dx.doi.org/10.3343/alm.2014.34.2.118] [PMID: 24624347]
[6]
Khuroo, M.S.; Khuroo, M.S.; Khuroo, N.S.; Hepatitis, E.; Hepatitis, E. Discovery, global impact, control and cure. World J. Gastroenterol., 2016, 22(31), 7030-7045.
[http://dx.doi.org/10.3748/wjg.v22.i31.7030] [PMID: 27610014]
[7]
Kamar, N.; Dalton, H.R.; Abravanel, F.; Izopet, J. Hepatitis E virus infection. Clin. Microbiol. Rev., 2014, 27(1), 116-138.
[http://dx.doi.org/10.1128/CMR.00057-13] [PMID: 24396139]
[8]
Teshale, E.H.; Hu, D.J.; Hepatitis, E.; Hepatitis, E. Epidemiology and prevention. World J. Hepatol., 2011, 3(12), 285-291.
[http://dx.doi.org/10.4254/wjh.v3.i12.285] [PMID: 22216368]
[9]
Taherkhani, R.; Farshadpour, F. Epidemiology of Hepatitis E in pregnant women and children in Iran: A General Overview. J. Clin. Transl. Hepatol., 2016, 4(3), 269-276.
[PMID: 27777896]
[10]
Pérez-Gracia, M.T.; García, M.; Suay, B.; Mateos-Lindemann, M.L. Current knowledge on Hepatitis E. J. Clin. Transl. Hepatol., 2015, 3(2), 117-126.
[PMID: 26355220]
[11]
Farshadpour, F.; Taherkhani, R.; Ravanbod, M.R.; Eghbali, S.S.; Taherkhani, S.; Mahdavi, E. Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. PLoS One, 2018, 13(1)e0191090
[http://dx.doi.org/10.1371/journal.pone.0191090] [PMID: 29329329]
[12]
Obiri-Yeboah, D.; Asante Awuku, Y.; Adu, J.; Pappoe, F.; Obboh, E.; Nsiah, P.; Amoako-Sakyi, D.; Simpore, J. Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. PLoS One, 2018, 13(1)e0191685
[http://dx.doi.org/10.1371/journal.pone.0191685] [PMID: 29370271]
[13]
Farshadpour, F.; Taherkhani, R.; Makvandi, M. Prevalence of Hepatitis E virus among adults in south-west of Iran. Hepat. Res. Treat., 2015.2015759589
[http://dx.doi.org/10.1155/2015/759589] [PMID: 26199756]
[14]
Borkakoti, J.; Ahmed, G.; Kar, P. Report of a novel C1483W mutation in the hepatitis E virus polymerase in patients with acute liver failure. Infect. Genet. Evol., 2016, 44, 51-54.
[http://dx.doi.org/10.1016/j.meegid.2016.06.030] [PMID: 27320795]
[15]
Borkakoti, J.; Ahmed, G.; Rai, A.; Kar, P. Report of novel H105R, D29N, V27A mutations in the methyltransferase region of the HEV genome in patients with acute liver failure. J. Clin. Virol., 2017, 91, 1-4.
[http://dx.doi.org/10.1016/j.jcv.2017.03.017] [PMID: 28359977]
[16]
Sehgal, R.; Patra, S.; David, P.; Vyas, A.; Khanam, A.; Hissar, S.; Gupta, E.; Kumar, G.; Kottilil, S.; Maiwall, R.; Sarin, S.K.; Trehanpati, N. Impaired monocyte-macrophage functions and defective Toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure. Hepatology, 2015, 62(6), 1683-1696.
[http://dx.doi.org/10.1002/hep.28143] [PMID: 26331854]
[17]
Marano, G.; Vaglio, S.; Pupella, S.; Facco, G.; Bianchi, M.; Calizzani, G.; Candura, F.; Catalano, L.; Farina, B.; Lanzoni, M.; Piccinini, V.; Liumbruno, G.M.; Grazzini, G. Hepatitis E: an old infection with new implications. Blood Transfus., 2015, 13(1), 6-17.
[PMID: 25369613]
[18]
Mohsen, W.; Levy, M.T. Hepatitis A to E: what’s new? Intern. Med. J., 2017, 47(4), 380-389.
[http://dx.doi.org/10.1111/imj.13386] [PMID: 28401719]
[19]
Taherkhani, R.; Farshadpour, F. A new strategy for development of hepatitis E vaccine: Epitope-based vaccines. Pathog. Infect. Dis, 2015, 1, e933.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 3
Year: 2019
Page: [334 - 336]
Pages: 3
DOI: 10.2174/1871526518666180530075523
Price: $58

Article Metrics

PDF: 33